Skip to Main Content

Advertisement intended for health care professionals

Skip Nav Destination

First Edition

Research Article January 10 2025
Targeting DOT1L and EZH2 synergizes in breaking the germinal center identity of Diffuse Large B-cell Lymphoma
Research Article January 10 2025
High-throughput drug screening identifies SMAC mimetics as enhancers of NK cell cytotoxicity in chronic myeloid leukemia
Research Article January 10 2025
Donor Regulatory T-Cell Therapy to Prevent Graft-Versus-Host Disease
Research Article January 10 2025
Epcoritamab plus GemOx in transplant-ineligible relapsed/refractory DLBCL: results from the EPCORE NHL-2 trial
Discussion January 8 2025
Introduction to a review series on reflections on a quarter century of TKIs in CML
Research Article January 7 2025
Potentiating CD20 monoclonal antibody therapy by targeting complement C3 fragment covalently deposited on lymphoma cells
Research Article January 7 2025
Selenoprotein-Mediated Redox Regulation Shapes the Cell Fate of HSCs and Mature Lineages
Research Article January 7 2025
Measurable residual disease and posttransplantation gilteritinib maintenance for patients with FLT3-ITD-mutated AML
Research Article January 7 2025
Targeting Senescent Stemlike Subpopulations in Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia
Research Article January 6 2025
Glucarpidase for Treatment of High-Dose Methotrexate Toxicity
Review Article January 6 2025
The Evolution of Treatment-Free Remission
Review Article December 30 2024
High-Risk MCL: Recognition and Treatment
Review Article December 30 2024
How I use noninvasive prenatal testing for red blood cell and platelet antigens
Review Article December 30 2024
Genetic subtypes of B-cell acute lymphoblastic leukemia in adults
Review Article December 30 2024
How I Diagnose and Treat Acute Infection-associated Purpura Fulminans
Research Article December 30 2024
Targeting Enterobacter cloacae attenuates osteolysis by reducing ammonium in multiple myeloma
Review Article December 30 2024
How I Manage Patients with Unexplained Cytopenia
Research Article December 30 2024
Prognostic and therapeutic implications of measurable residual disease levels during remission induction of childhood ALL
Review Article December 30 2024
FDA-approved therapies for chronic GVHD
Research Article December 30 2024
Odronextamab monotherapy in R/R DLBCL after progression with CAR T-cell therapy: Primary analysis of the ELM-1 study
Research Article December 27 2024
Targeting WDR5/ATAD2 signaling by the CK2/Ikaros axis demonstrates therapeutic efficacy in T-ALL
Research Article December 27 2024
α-Ketoglutarate dehydrogenase is a therapeutic vulnerability in acute myeloid leukemia
Research Article December 27 2024
Cullin-5 controls the number of megakaryocyte-committed stem cells to prevent thrombocytosis in mice
Research Article December 27 2024
Population dynamics modeling reveals that myeloid bias involves both HSC differentiation and progenitor proliferation biases
Research Article December 27 2024
DNTT-mediated DNA Damage Response Drives Inotuzumab Ozogamicin Resistance in B-cell Acute Lymphoblastic Leukemia
Review Article December 27 2024
Novel Treatment Strategies for Chronic Myeloid Leukemia
Review Article December 24 2024
How I Treat AML relapse after allogeneic HCT
Review Article December 24 2024
Menin inhibitors in the treatment of acute myeloid leukemia
Letter December 24 2024
Non-V600E BRAF mutations and treatment for Hairy Cell Leukemia
Research Article December 19 2024
Long-Term Efficacy and Safety of Danicopan as Add-On Therapy to Ravulizumab or Eculizumab in PNH With Significant EVH
Discussion December 19 2024
CAR T-cells in autoimmunity: game changer or stepping stone?
Brief Report December 19 2024
Approaching Hypercalcemia in Monoclonal Gammopathy of Undetermined Significance: Insights from the iStopMM study
Review Article December 19 2024
How I treat quantitative fibrinogen disorders
Research Article December 18 2024
Deficiency of neutrophil gelatinase-associated lipocalin elicits Hemophilia-like bleeding and clotting disorder
Research Article December 18 2024
Mutations in AMBRA1 aggravate β-thalassemia by impairing autophagy-mediated clearance of free α-globin
Research Article December 18 2024
Oral Inflammation and Microbiome Dysbiosis Exacerbate Chronic Graft-versus-host Disease
Research Article December 18 2024
Heme promotes venetoclax resistance in multiple myeloma through MEK-ERK signaling and purine biosynthesis
Retraction December 17 2024
130(1)11 Xu (Fan) retraction
Research Article December 16 2024
DLBclass: A Probabilistic Molecular Classifier to Guide Clinical Investigation and Practice in DLBCL
Research Article December 12 2024
Air pollution is associated with increased risk of venous thromboembolism: the Multi-Ethnic Study of Atherosclerosis
Research Article December 11 2024
Single-cell epigenetic and clonal analysis decodes disease progression in pediatric acute myeloid leukemia
Research Article December 10 2024
Inflammation-driven NFκB signaling represses Ferroportin transcription in macrophages via HDAC 1 and 3
Research Article December 10 2024
IFN-I promotes T cell-independent immunity and RBC autoantibodies via modulation of B-1 cell subsets in murine SCD
Research Article December 10 2024
Progressive chromatin rewiring by ETO2::GLIS2 revealed in a human iPSC model of pediatric leukemia initiation
Research Article December 9 2024
Acute resistance to BET inhibitors remodels compensatory transcriptional programs via p300 coactivation
Research Article December 9 2024
ADAR1-regulated cytoplasmic dsRNA-sensing pathway is a novel mechanism of lenalidomide resistance in multiple myeloma
Research Article December 9 2024
Tumor burden quantified by Soluble B-Cell Maturation Antigen and Metabolic Tumor Volume determine myeloma CAR-T outcomes
Research Article December 9 2024
Anti-CD19 antibody cotreatment enhances serial killing activity of anti-CD19 CAR-T/-NK cells and reduces trogocytosis
Research Article December 9 2024
The GATA-3-dependent transcriptome and tumor microenvironment are regulated by eIF4E and XPO1 in T-cell lymphomas
Research Article December 9 2024
Efficacy and Safety of Venetoclax Plus Azacitidine for Patients With Treatment-Naive High-Risk Myelodysplastic Syndromes
Page 1 of 3
Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals